EASI Genomics: an EU-funded project to provide free-of-charge access to sequencing technologies Blog Post

EASI-Genomics –a new European project to provide easy access to sequencing technologies and analysis to researchers– has opened its 1st call for proposals today, 25th March. Ivo Gut,  Director of the Centro Nacional de Análisis Genómico of the Centre for Genomic Regulation (CNAG-CRG) coordinates the consortium, that  will handle between 150 and 300 projects over a period of 4 years with a total budget of 10 M€ funded under the European Union’s research and innovation programme Horizon 2020.

 

Laboratorios Ordesa are leading a research project on food allergies Blog Post

Laboratorios Ordesa head up the TOLERA consortium, which was conceived with the aim of developing workable solutions for the food industry that provide safer and more effective foodstuffs and ingredients to prevent people from developing food intolerances and allergies. Under the framework of this project—driven by the Centre for the Development of Industrial Technology (CDTI) with a budget of €8.1 million for the 2018-2021 period—the company will promote various research studies, both their own at their research centre in Barcelona Science Park, and in partnership with other companies, universities and public and private R&D centres.

 

IBEC, ISGlobal and Bioiberica join forces to study new strategies based on nanomedicine to combat malaria Blog Post

The Institute for Bioengineering of Catalonia (IBEC), the Barcelona Institute for Global Health (ISGlobal) and the biotech firm Bioiberica have signed a partnership agreement to study the development of new compounds derived from heparin to combat malaria. The partnership, which was officially announced this morning at the international Biospain meeting held in Bilbao.

 

Endor Nanotechnologies develops a treatment against cancer of the pancreas and colon capable of overcoming tumor resistance Blog Post

Endor Nanotechnologies –based at the Barcelona Science Park (PCB)– will start Phase II clinical trials on a new innovative treatment for cancer of the pancreas and colon, capable of preventing the tumor from becoming resistant. This new innovative treatment developped by Endor won the Best Biotechnology Product Award 2016 at the European Biotechnology Congress, organized by the European Biotechnology Thematic Network Association (EBTNA) last May in Riga, Latvia Republic.

 

New analysis services regarding Industrial Hygiene of CCiTUB in partnership with the Ministry for Business and Labour Blog Post

October 2, was carried out in the building of the Scientific and Technological Centers (CCiTUB) Lluís in Solé i Sabarís street an official visit to inaugurate the new analysis services regarding Industrial Hygiene will provide the Universitat de Barcelona (UB) through CCiTUB. This new analysis service is part of the agreement signed between the UB and the Ministry for Business and Labour of the Government of Catalonia with objectives to promote the cooperation between the two institutions regarding the analytical determinations both environmental and biological evaluation related to exposure to various pollutants in the workplace.

 

Lessons Learned session: Designing new strategies to be more competitive in Drug Discovery Blog Post

On 26 February, Biocat and CataloniaBio will be hosting a conference at the Barcerlona Science Park that will bring together several experts and professionals from the field of life sciences to share their experiences and points of view relative to the process involved in the discovery of new drugs. The workshop, entitled Drug Discovery: Design of new strategies to become more competitive, is part of the series ‘Lessons Learned: Sharing experiences to foster competitiveness ‘, a knowledge and networking forum aimed at sharing experiences to gain further insight into the different knowledge strategies and capabilities needed to strengthen competitiveness of biotech companies.

 

Endor Nanotechnologies wins the 2014 Senen Vilaró Award for best innovative company Blog Post

Endor Nanotechnologies, based at the Parc Cientific de Barcelona (PCB), has won the 2014 Senén Vilaró Award for best innovative company. The award is endowed  with 10,000 euros, and it’s one of the four prizes conferred by the Board of Trustees and the Bosch i Gimpera Foundation (FBG). The Antoni Caparros Prize also awarded a second prize of 2,000 euros to the training program in organ donation and transplantation led by Martin Manyalich, president of the DTI Foundation – Donation & Transplantation Institute– also located at the PCB-, associated professor of the Faculty Medicine and consultant in transplantation at the UB Hospital Clinic of Barcelona.
 

Meeting with IRB at Barcelona Science Park on ‘Key Enabling Technologies’ (KET) Blog Post

Under the framework of the Cicle de Jornades KET, the Cercle Tecnològic de Catalunya (CTEcno), Network of Science and Technology Parks of Catalonia (XPCAT) and the Cercle per al ConeixementSocietat Econòmica Barcelonesa d’Amics del País, are holding a meeting with the Institute for Research in Biomedicine Barcelona (IRB Barcelona) onTecnologies KET. The event will take place on 22 October 2014 at the Parc Científic de Barcelona (PCB).

Es posa en marxa un projecte per impulsar sinergies en els serveis corporatius dins del Grup UBTO TRANSLATE >>> Blog Post

La UB ha posat en marxa el projecte Sinergies en els serveis corporatius dins del Grup UB. La iniciativa està impulsada des del Vicerectorat del Grup UB, TIC i Serveis Comuns, amb la col•laboració de personal de les principals fundacions del Grup UB i de determinades unitats transversals de la UB. D’aquesta manera, es pretén propiciar un canvi cultural en la manera de treballar i de col•laborar entre totes les entitats de l’entorn UB i assolir millores qualitatives i de costos en la gestió de serveis.

First observation of a human HAT, key proteins in numerous pathologies Blog Post

A study published this week in the journal Proceedings of the National Academy of Sciences USA (PNAS) has revealed the first structure of one of the eight HATs (heteromeric amino acid transporters). Achieved through collaboration between biochemists at Institute for Research in Biomedicine (IRB), experts in electronic microscopy at the University of Bern, and computational biologists in the Joint IRB-BSC Programme, this breakthrough paves the way for further research into the functions of the other seven HATs and the resolution of their structures. Moreover, this study provides the first sufficiently detailed structural data to tackle their inhibition through drugs.